Answers are grounded in this paper and cite their sources.
This editorial highlights a positive shift in clinical practice towards guideline-directed management of hypertensive crises, including increased use of oral agents for urgencies and avoidance of sublingual nifedipine.
A rapid, marked and persistent rise in blood pressure (BP) levels above 180/120 mmHg is a clinical condition currently defined as hypertensive emergency or urgency in the presence or absence of acute signs of hypertension-mediated organ damage, respectively [1]. Beyond the magnitude of BP rise and absolute BP levels, early recognition of these conditions is crucial from both a prognostic and a therapeutic point of view. Indeed, current European guidelines recommend clinical observation with repeated BP measurements and gradual BP reductions throughout the administration of oral antihypertensive drug therapies in individuals with hypertensive urgencies [2]. On the other hand, patients with hypertensive emergencies should immediately receive pharmacological and nonpharmacological interventions for lowering BP levels, mostly through the administration of intravenous drugs, and undergo specific treatment protocols for the clinical management of associated clinical conditions, such as acute coronary syndromes, stroke, pulmonary oedema, eclampsia, and aortic dissection [2]. Similar recommendations have been issued by the United States guidelines on hypertension [3]. Whatever the cause and in any clinical presentation, two aspects should be always taken in mind when approaching hypertensive emergencies or urgencies. The first is that there is lack of evidence from randomized controlled trials for the best therapeutic protocol or drug to adopt. The second is that in both cases, BP reductions should be obtained gradually, avoiding excessive BP drops and complications because of low blood flow to the brain, the kidney or the heart. In view of the widespread prevalence of hypertension in both low-income and high-income countries, and considering the progressive increase in the number of hospitalizations because of hypertension or hypertension-related comorbidities, greater attention has been devoted to hypertension emergencies or urgencies over the last few years. In particular, several clinical studies have been carried out to identify predisposing factors that may promote hypertensive emergencies or urgencies; these studies demonstrated that the most relevant factors responsible for the rapid rise of BP levels are represented by low adherence to prescribed antihypertensive medications, discontinuation from assumption of BP-lowering drugs, overuse (or abuse) of illicit substances or recreational drugs, and poor control of concomitant risk factors (e.g. smoke, obesity, hypercholesterolemia, and diabetes) [4,5]. In addition, several hypertensive phenotypes, such as masked hypertension and white-coat hypertension, have been related to an increased risk of hospitalization because of uncontrolled hypertension [6], highlighting the need for proper assessment of control of BP levels during the entire 24-hour period. In this issue of the Journal of Hypertension, Muiesan and co-workers describe the 7-year experience of the Emergency Department and their reference hypertension center at the Spedali Civili of Brescia, Italy, on hypertensive emergencies and urgencies [7]. The analysis they provide (which consists of the large amount of data collected over a 12-month period at two different times, 2008 and 2015) allows several considerations and favours some speculations. In this study population, patients presenting to the emergency department with hypertensive emergency or urgency (about 2% of the total admissions) were predominantly men and aged more than 60 years. All were affected by hypertension, and about one-third had also diabetes or previous cardiovascular events. SBP/DBP levels at entry were higher in hypertensive emergencies than in urgencies. Although no data were available on how many patients with hypertension were treated or not, these features allow to delineate a ‘phenotype’ of hypertensive patients at high risk of having hospitalization for an acute BP elevation, and thus to suggest some preventive therapeutic strategies to reduce the risk of this outcome. At entry, dyspnoea, chest pain, and headache were the most frequent symptoms in both conditions. In patients with hypertensive emergencies, the most frequent acute organ damage was stroke (38%), followed by pulmonary oedema (35%), and coronary syndrome (25%), which is in line with the evidence that uncontrolled hypertension is a main contributor to the risk of having all major cardiovascular outcomes, not only coronary disease [8], but also stroke, left ventricular dysfunction, and congestive heart failure [9]. In this regard, current European guidelines [2] recommend to achieve lower BP treatment targets than those recommended by previous guidelines [10], thus highlighting the need for a more effective BP control by treatment. It remains to be seen, however, whether these lower recommended targets will have a favourable reflection on the risk of developing a hypertension emergency or urgency Another aspect of particular relevance in the study of Muiesan and co-workers [7] was the detailed analysis of the therapeutic approaches adopted for treating hypertensive emergencies and urgencies in 2008 compared with those applied in 2015, that is, over a period during which the influential medical documents on this issue were a position paper from ESC published in 2006 [11] and the ESH/ESC guidelines released in 2013 [10]). In the second observation period, that is, 2015, larger proportions of patients with hypertensive urgencies received oral drugs, mostly dihydropyridinic calcium-channel blockers, and drugs blocking the renin–angiotensin system, than those in the first observation period, in which intravenous (furosemide, nitrates) or intramuscular (clonidine) drugs were more frequently adopted. As properly observed by the authors, this suggests a clear therapeutic shift of the way physicians address hypertension emergency and urgency. Interestingly, antihypertensive treatment for patients with hypertensive emergencies was driven by the specificity of concomitant diseases in both observation periods. That is, patients with pulmonary oedema or coronary syndrome were more frequently treated (and received more intravenous drugs, such as nitrates, beta-blockers, and loop diuretics) than those with stroke from any cause. This reflects the indications of guidelines to avoid excessive BP reductions during the acute phases of stroke [12]. Use of sublingual nifedipine was progressively abandoned, and in 2015 avoided in all patients, as repeatedly recommended by guidelines. A final consideration is that almost all patients with hypertensive emergencies were admitted to hospital as inpatients, whereas only 40–45% of patients with hypertensive urgencies required hospitalization. This implies that more accurate treatment approach with high level of adherence to prescribed medications and sustained BP control during the 24-hour period would ideally reduce number of unnecessary hospitalizations because of uncontrolled hypertension, thus reducing costs related to hypertensive urgencies and ameliorating clinical outcomes of hypertensive emergencies. ACKNOWLEDGEMENTS Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Tocci et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: